Retatrutide , developed by Eli Lilly, is a novel triple agonist that simultaneously activates three receptors: GLP-1 (glucagon-like peptide-1) receptor reduces appetite and slows gastric emptying GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin secretion
Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice
Im not an expert in this area, so I really valued her advice on how to support my skin in ways that fit where I am right now
BPC 157 (Body Protection Compound 157) is a peptide known for its regenerative properties
It is not an FDA-approved active for the treatment of any hair-loss condition, and it has never been through the drug-approval pathway for such an indication
5-Amino-1MQ is a substrate-mimetic inhibitor occupying the nicotinamide binding site, with a reported IC of 1.2 0.1 M (Neelakantan et al., J Med Chem, 2017)